UBS O'Connor’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

UBS O'Connor’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-785,841	Closed	-$170M	–	1144
2021 Q1	$170M	Buy	+785,841	New	+$148M	2.46%	9
2013 Q3	–	Sell	-35,060	Closed	-$304K	–	600
2013 Q2	$304K	Buy	+35,060	New	+$310K	0.01%	440

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

UBS O'Connor's GWPH Position: Q2 2021 in Review

UBS O'Connor sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 785,841 shares — an estimated $170M sold.

UBS O'Connor first reported a position in GWPH in Q2 2013 and held it in 2 quarters. The position peaked at $170M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

UBS O'Connor reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
UBS O'Connor sold 785,841 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $170M.
UBS O'Connor first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2013 and held it in 2 quarters.
UBS O'Connor's GW Pharmaceuticals Plc American Depositary Shares position peaked at $170M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.